Epithelial basement membrane dystrophy (EBMD) and Fuchs endothelial dystrophy are two of the more commonly encountered corneal conditions in comprehensive and anterior segment ophthalmology practice. In many cases, epithelial basement membrane abnormalities, in the presence of endothelial disease, can be attributed to primary endothelial failure leading to corneal oedema and subsequent epitheliopathy. This article will provide an overview of both EBMD and Fuchs endothelial dystrophy and will discuss the role of epithelial debridement for epithelial basement membrane abnormalities in the setting of endothelial disease. We will also present a long-term update of our post-treatment results from patients in a previous report 1 and also present two more cases of epithelial debridement performed after endothelial keratoplasty.
In a prospective, double-masked, randomised, controlled trial, Wong and colleagues investigated debridement techniques in 48 patients with recurrent erosion syndrome secondary to EBMD or trauma. 13 Patients received either simple epithelial debridement with cellulose sponge or epithelial debridement with diamond burr polishing and superficial keratectomy. Major recurrence defined as epithelial defects occurred in 56.5% of patients in the epithelial debridement group and 4.0% of patients in the diamond burr group. Minor recurrences (defined as pain, redness, tearing and photophobia not severe enough for the patient to seek medical care) occurred in 65.2% in the epithelial debridement group and 20.0% in the diamond burr group. In retrospective case studies involving multiple surgeons and a varied number of cases, the difference between the two groups is less pronounced, with recurrence of recurrent erosions occurring in 11-18% in patients undergoing simple debridement 7,9 compared with 4-25% in patients undergoing debridement combined with diamond burr polishing. 14 We previously reported on using epithelial debridement, a widely accepted method of treating EBMD, to treat the epithelial changes coincident with endothelial disorders. 1 We herein describe our results and provide longer follow-up of the case series, illustrating different clinical scenarios in which epithelial basement membrane debridement was useful in patients who had EBMD associated with endothelial disease (see Table 1 ). Overall, the mean change in BSCVA post-operatively was two lines improvement in Snellen acuity (range zero to three lines) at onemonth follow-up. All of the eyes showed significant keratometric and topographic normalisation. Furthermore, epithelial debridement was refractively neutral, unlike in the study by Itty and associates, 7 which showed a wide range of refractive changes. Three of our five eyes experienced a decrease in pachymetry values post-operatively, including one eye with ICE syndrome that had over 100μm decrease in total corneal thickness after simple epithelial debridement. In one report of patients with Fuchs, with and without epithelial oedema, the average difference in pachymetry was 58μm. 26 Although epithelial debridement of EBMD in the setting of endothelial disease may be temporising, it is nonetheless a useful measure to improve ultimate visual outcome. In our series, the need for definitive keratoplasty in two eyes was delayed for three and five months, at which time DSAEKs were successfully performed. One case (patient 2) for whom penetrating keratoplasty was initially planned was able to receive DSAEK because of significant normalisation of the epithelium after debridement. In other cases, debridement allowed for reliable biometric calculations for cataract extraction and delay of DSAEK, with ultimate significant improvement in visual acuity.
Epithelial Debridement for Epithelial Basement Membrane Abnormalities in Endothelial Disorders
Here, we also present two patients in whom epithelial debridement for EBMD after DSAEK lead to favourable visual outcomes. 
